Uppsala, Sweden / Denver, USA – [May 19, 2025]
Uppsala Clinical Research Center (UCR), Sweden’s leading Academic Research Organization, and CPC Clinical Research, a distinguished U.S.-based Academic Research Organization affiliated with the University of Colorado, have signed a Memorandum of Understanding (MoU) to establish a strategic collaboration focused on advancing clinical research and life sciences globally.
This partnership aims to strengthen the ability of both organizations to support and implement high-quality, investigator-initiated research by combining their unique expertise in clinical trial management, registry-based research, data analysis, and scientific advisory services. The collaboration will emphasize innovation, sustainability, and global impact.
“This agreement provides a framework for joint efforts in advanced study design, quality registries, and scientific support. Our shared ambition is to improve global health outcomes through high-quality clinical research,”
- says Maria Eriksson Svensson, Director of UCR.
“Our collaboration with UCR enhances our capacity to lead impactful, academic-driven research globally. We share a deep commitment to scientific integrity, independence, and efficiency,”
- says Marc P. Bonaca, Executive Director at CPC Clinical Research.
Key areas of collaboration will include:
- Clinical trial design methodologies, innovating decentralized and registry-based research approaches to enhance accessibility and efficiency.
- Endpoint adjudication expertise, ensuring accurate and reliable assessment of clinical trial outcomes.
- Data and safety monitoring boards expertise, providing rigorous oversight to maintain the highest standards of participant safety and data integrity
- Sustainability of investigator-initiated research programs, Supporting and fostering investigator-led research to drive continuous innovation and discovery.
About UCR
Uppsala Clinical Research (UCR) center is the leading clinical Academic Research Organization (ARO) in Sweden, providing in-house expertise to academia and industry on all aspects of clinical research and improved health care. UCR’s services include management of clinical and observational studies, biostatistics, clinical quality registries, and clinical event adjudication. UCR has established a complete service package to initiate, plan, conduct, analyze, report and publish local investigator-initiated studies as well as international multicenter trials. UCR is the largest of the six Swedish centers for National Clinical Quality Registries. One of UCR’s goals is to develop and support the national and local quality registries it manages, and also to provide world-leading expertise in the development of research registries and design and conduct of registry based randomized clinical trials (RRCTs).
About CPC Clinical Research
CPC Clinical Research, is an Academic Research Organization (ARO) established in 1989 by the University of Colorado as an independently run and managed non-profit organization, with faculty employees drawn from the University of Colorado as well as multiple other institutions across the U.S.A. It is recognized for its expertise in comprehensive clinical trial design and management, offering leadership and management services for Phase I to IV clinical trials to sponsors worldwide. CPC distinguishes itself through its academic leadership and operational expertise, aiming to optimize the quality of clinical research and improve health outcomes.
The organization has over 30 years of experience in managing clinical trials and has developed innovative programs such as the Endpoint Quality Intervention Program (EQuIP®) to reduce variability in endpoint data collection. CPC is also associated with the University of Colorado Charles C Gates Center for Regenerative Medicine & Stem Cell Biology, focusing on developing new therapies for diseases like heart and vascular diseases.
CPC Research has conducted numerous clinical trials, contributing to evidence-based improvements in cardiometabolic health, prevention, and care of patients with complex cardiovascular diseases. Therapies evaluated include novel therapies for vascular disease, lipid lowering, diabetes medications, anti-inflammatory therapies, and anti-hypertensive
therapies. Research methods include randomized trials, real world research, implementation science, and others. The organization emphasizes scientific integrity, transparency, and community engagement in its research activities. There is a focus on delivering high quality research in a pragmatic and efficient manner.
For more information, please contact: